Projects per year
Personal profile
Area of Expertise
The focus of my research has two broad aims.
The first aim is to screen compounds that will attenuate the subjective and reinforcing effects of abused drugs as part of a NIDA-funded contract searching for effective treatment drugs for addiction to cocaine, methamphetamine, nicotine, and marijuana.
The second aim is to evaluate the potential abuse liability of novel designer drugs that are increasingly available as "legal" alternatives to controlled substances. We use drug discrimination procedures which assess the subjective effects of common drugs of abuse such as cocaine, methamphetamine, nicotine, and marijuana, with designer drugs like MDMA (Ecstasy), with opioids like morphine, or with hallucinogens like LSD. We also test the reinforcing/rewarding effects of drugs using the conditioned place preference and self-administration assays.
The first aim is to screen compounds that will attenuate the subjective and reinforcing effects of abused drugs as part of a NIDA-funded contract searching for effective treatment drugs for addiction to cocaine, methamphetamine, nicotine, and marijuana.
The second aim is to evaluate the potential abuse liability of novel designer drugs that are increasingly available as "legal" alternatives to controlled substances. We use drug discrimination procedures which assess the subjective effects of common drugs of abuse such as cocaine, methamphetamine, nicotine, and marijuana, with designer drugs like MDMA (Ecstasy), with opioids like morphine, or with hallucinogens like LSD. We also test the reinforcing/rewarding effects of drugs using the conditioned place preference and self-administration assays.
Education/Academic qualification
BA in Behavioral Science, The University of Chicago
MA in Behavior Science, University of Houston
PhD in Psychology , Utah State University
Fingerprint
Dive into the research topics where Michael Gatch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluation of Abuse Potential
Shetty, R. (PI), Forster, M. (CoI) & Gatch, M. (CoI)
4/02/25 → 3/02/26
Project: Research
-
Evaluation of Abuse Potential
Shetty, R. (PI), Forster, M. (CoI) & Gatch, M. (CoI)
30/09/24 → 29/09/29
Project: Research
-
Using rodent behavioral models
Forster, M. (PI), Gatch, M. (CoI), Shetty, R. (CoI) & Sumien, N. (CoI)
NIDA: National Institute on Drug Abuse
4/01/23 → 3/01/28
Project: Research
-
-
-
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
Carbonaro, T. M., Eshleman, A. J., Forster, M. J., Cheng, K., Rice, K. C. & Gatch, M. B., Jan 2015, In: Psychopharmacology. 232, 1, p. 275-284 10 p.Research output: Contribution to journal › Article › peer-review
-
Behavioral effects of four novel synthetic cathinone analogs in rodents
Gatch, M. B., Shetty, R. A., Sumien, N. & Forster, M. J., Jul 2021, In: Addiction Biology. 26, 4, e12987.Research output: Contribution to journal › Article › peer-review
-
Erratum: Naloxonazine antagonism of levorphanol-induced antinociception and respiratory depression in rhesus monkeys (European Journal of Pharmacology 298 (1996) (31-36))
Gatch, M. B., Liguori, A., Negus, S. S., Mello, N. K. & Bergman, J., 1996, In: European Journal of Pharmacology. 312, 3, p. 389 1 p.Research output: Contribution to journal › Comment/debate
-
The effects of adenosine ligands R-PIA and CPT on ethanol withdrawal
Gatch, M. B., Wallis, C. J. & Lal, H., Aug 1999, In: Alcohol. 19, 1, p. 9-14 6 p.Research output: Contribution to journal › Article › peer-review
-
Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats
Gatch, M. B. & Forster, M. J., 1 May 2016, In: Psychopharmacology. 233, 10, p. 1901-1910 10 p.Research output: Contribution to journal › Article › peer-review